CLINICAL VALIDATION OF THE ANYPLEX™ II HPV HR DETECTION FOR PRIMARY CERVICAL CANCER SCREENING

被引：0
|
作者：
Jung, Sunkyung [1 ]
Kim, Jongki [1 ]
Lee, Kangil [2 ]
机构：
[1] Seegene Med Fdn, Mol Diagnost Testing Ctr, Seoul, South Korea
[2] Kangwon Natl Univ, Dept Phys, Chunchon, South Korea
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1163
引用
收藏
页码：237 / 237
页数：1
相关论文
共 50 条
  • [1] Clinical Validation of Anyplex II HPV HR Detection Test for Cervical Cancer Screening in Korea
    Jung, Sunkyung
    Lee, Byungdoo
    Lee, Kap No
    Kim, Yonggoo
    Oh, Eun-Jee
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2016, 140 (03) : 276 - 280
  • [2] Clinical validation of Anyplex™ II HPV HR Detection according to the guidelines for HPV test requirements for cervical cancer screening
    Hesselink, A. T.
    Sahli, R.
    Berkhof, J.
    Snijders, P. J. F.
    van der Salm, M. L.
    Agard, D.
    Bleeker, M. C. G.
    Heideman, D. A. M.
    JOURNAL OF CLINICAL VIROLOGY, 2016, 76 : 36 - 39
  • [3] Concordance of Anyplex™ II HPV HR assays with reference HPV assays in cervical cancer screening: Systematic review
    Biazin, Habtamu
    JOURNAL OF VIROLOGICAL METHODS, 2022, 301
  • [4] Allplex HPV HR Detection assay fulfils all clinical performance and reproducibility validation requirements for primary cervical cancer screening
    Valencak, Anja Ostrbenk
    Cuschieri, Kate
    Connor, Linzi
    Zore, Andrej
    Smrkolj, Spela
    Poljak, Mario
    JOURNAL OF CLINICAL VIROLOGY, 2024, 170
  • [5] Anyplex II HPV28 detection and Anyplex II HPV HR detection assays are highly concordant with other commercial assays for detection of high-risk HPV genotypes in women with high grade cervical abnormalities
    A. M. Cornall
    M. Poljak
    S. M. Garland
    S. Phillips
    J. H. Tan
    D. A. Machalek
    M. A. Quinn
    S. N. Tabrizi
    European Journal of Clinical Microbiology & Infectious Diseases, 2017, 36 : 545 - 551
  • [6] Anyplex II HPV28 detection and Anyplex II HPV HR detection assays are highly concordant with other commercial assays for detection of high-risk HPV genotypes in women with high grade cervical abnormalities
    Cornall, A. M.
    Poljak, M.
    Garland, S. M.
    Phillips, S.
    Tan, J. H.
    Machalek, D. A.
    Quinn, M. A.
    Tabrizi, S. N.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2017, 36 (03) : 545 - 551
  • [7] Clinical Validation of the Vitro HPV Screening Assay for Its Use in Primary Cervical Cancer Screening
    Bellosillo, Beatriz
    Ibanez, Raquel
    Roura, Esther
    Monfil, Laura
    Asensio-Puig, Laura
    Alvarez, Isabel
    Muset, Merce
    Florencia, Yolanda
    Paytubi, Sonia
    de Andres-Pablo, Alvaro
    Calvo, Susana
    Serrano-Munne, Laia
    Pavon, Miguel angel
    Lloveras, Belen
    CANCERS, 2024, 16 (07)
  • [8] Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework
    Ostrbenk, Anja
    Xu, Lan
    Arbyn, Marc
    Poljalc, Mario
    JOURNAL OF CLINICAL MICROBIOLOGY, 2018, 56 (11)
  • [9] Primary HPV screening for cervical cancer
    Bhatla, Neerja
    Singhal, Seema
    BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2020, 65 : 98 - 108
  • [10] The Clinical Role of HPV Testing in Primary and Secondary Cervical Cancer Screening
    Hoste, G.
    Vossaert, K.
    Poppe, W. A. J.
    OBSTETRICS AND GYNECOLOGY INTERNATIONAL, 2013, 2013
12345